








Alfonso Gautieria,b,c,1, Fabian S. Passinia,b,1, Manuel Guizar-Sicairosd, Giulia Carimatie, Piero Volpie, Matteo 




a Department of Orthopedics, Balgrist University Hospital, University of Zurich, 8008 Zurich, Switzerland 
b Institute for Biomechanics, ETH Zurich, 8093 Zurich, Switzerland 
c Department of Electronics, Information and Bioengineering, Politecnico di Milano, Piazza Leonardo da 
Vinci 32, 20133 Milano, Italy 
d Paul Scherrer Institute, 5232 Villigen PSIVilligen, Switzerland 
e Department of Knee Orthopedic and Sports Traumatology Unit, Humanitas Research Hospital, 20089 
Rozzano, Italy 
f IRCCS Ist Ortoped Galeazzi, Cell & Tissue Engineering Lab, 20161 Milan, Italy 
 
 
1 These authors contributed equally 
2 To whom correspondence should be addressed:  
Prof. Jess G. Snedeker 
Uniklinik Balgrist / ETH Zurich 
Lengghalde 5 8008 Zurich 












Concurrent with a progressive loss of regenerative capacity, connective tissue aging is characterized by a 
progressive accumulation of Advanced Glycation End-products (AGEs). Besides being part of the typical 
aging process, type II diabetics are particularly affected by AGE accumulation due to abnormally high levels 
of systemic glucose that increases the glycation rate of long-lived proteins such as collagen. Although AGEs 
are associated with a wide range of clinical disorders, the mechanisms by which AGEs contribute to 
connective tissue disease in aging and diabetes are still poorly understood. The present study harnesses 
advanced multiscale imaging techniques to characterize a widely employed in vitro model of ribose induced 
collagen aging and further benchmarks these data against experiments on native human tissues from 
donors of different age. These efforts yield unprecedented insight into the mechanical changes in collagen 
tissues across hierarchical scales from molecular, to fiber, to tissue-levels. We observed a linear increase in 
molecular spacing (from 1.45 nm to 1.5 nm) and a decrease in the D-period length (from 67.5 nm to 67.1 
nm) in aged tissues, both using the ribose model of in vitro glycation and in native human probes. 
Multiscale mechanical analysis of in vitro glycated tendons strongly suggests that AGEs reduce tissue 
viscoelasticity by severely limiting fiber-fiber and fibril-fibril sliding. This study lays an important foundation 
for interpreting the functional and biological effects of AGEs in collagen connective tissues, by exploiting 
experimental models of AGEs crosslinking and benchmarking them for the first time against endogenous 
AGEs in native tissue. 
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Among the many age- and diabetes-related functional changes affecting human tissues there is a 
characteristic increase in rates of tissue injury with concurrently reduced healing capacity [1]. While the 
causes of these changes are multifactor, the accumulation of non-enzymatic crosslinks within the family of 
advanced glycation end-products (AGEs) is increasingly thought to play a role [2]. Formation of AGEs is both 
spontaneous and quite slow, affecting only proteins with relatively long half-lives and which contain 
exposed lysine residues [3-6]. In these respects, fibrillar collagens are highly susceptible to glycation. While 
collagen half-life varies between tissues it remains considerably long, ranging from 1 to 2 years for type I 
collagen in  bone, to 10-15 years in skin, and over 100 years for the type II collagens in cartilage [7-9]. Aside 
from protein longevity, another factor that influences the formation of AGEs is the base level of glucose in 
the bloodstream. Hyperglycemia related to diabetes is thus a second important cause of AGE formation and 
accumulation [10, 11]. 
 
Biochemically, the glycation reaction initiates with the formation of a reversible Schiff base between a 
carbohydrate, typically glucose or ribose [12], and a protein amino group (e.g., a lysine side-chain). The 
unstable Schiff base becomes a stable keto amine intermediate, usually referred to as Amadori product. 
Over the course of months or years a complex series of reactions eventually can lead to formation of 
various AGEs, which can be either protein adducts or crosslinks (Fig. 1A) [13]. Recently, it has been found 
that among all different AGEs in human tissues the most abundant is glucosepane, a lysine-arginine cross-
linking product [14, 15].  
 
Functionally, AGEs have been implicated in a range of deleterious physiological effects that can be divided 
into two major categories. On one hand, they alter molecular recognition [16] by modifying the 
biochemistry of specific protein binding sites [17]. On the other hand, AGEs crosslinks such as glucosepane 
are known to alter the mechanical properties of load bearing proteins such as collagen [18, 19] , leading to 
stiffer tissues and decreased viscoelasticity [20-22]. Both these alterations at the molecular level can 
participate in generating a cascade of adverse effects including arterial stiffening [23], atherosclerosis [24], 
nephropathy [25], retinopathy [26] and neuropathy [27]. From the biomechanical standpoint, 
intermolecular cross-links are known to increase tissue stiffness, mechanical load to failure and 
denaturation temperatures of collagen tissue. At the same time reduced mechanical robustness of AGE 
crosslinked tissue has been observed in animals [28, 29] and in humans [30, 31]. Because collagen tissue 
biology is so intimately related to extracellular matrix mechanics, AGE crosslinks may potentially drive the 
progression of connective tissue disease [2].  
 
Although macroscopic AGEs-mediated changes in collagen tissue properties have long been recognized, the 
functional and molecular consequences are yet to be fully elucidated. It has been suggested that glycation 
primarily affects collagen fibrils at their surface (Fig. 1B), due to the dense packing of collagen fibrils [32]. 
However, the molecular sites and hierarchical level at which AGEs are likely to accumulate within a tissue 
remains poorly understood. Previous studies from our group showed drastically decreased tendon 
viscoelasticity and brittle failure mode in tendons treated with methylglyoxal (MGO, a strong cross-linking 
agent) [33]. In bone the accumulation of AGEs has been correlated to decreased bone toughness and 
increased fracture risk [34, 35]. Although the role of AGEs has been investigated mostly at the tissue level, a 
few studies reported AGE-related mechanical changes in collagen fibrils of tendon tissue. Our group [36] 
found a higher failure resistance in MGO treated collagen fibrils as well as a reduction in the lateral sliding 
of collagen molecules within fibrils, while fibril modulus remained unchanged. Svensson et al. [21] observed 
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a three-phase behavior pattern in the stress-strain curves of human collagen fibrils. An initial increase in 
modulus was followed by a plateau phase and then by a final rise in modulus. The third region (stiffening 
before failure) was not noticed in the collagen fibrils from rat tail tendons. Since a higher AGEs content was 
detected in human fibrils, such mechanical changes have been suggested to be a consequence of glycation. 
 
 
Figure 1. Collagen and AGEs structures. Adducts and crosslinking AGEs on collagen molecule (A). Structure and size of 
collagen fibril and glycating sugars (B). Collagen fibrils (size is in the range 30-500 nm) are assemblies of collagen 
molecules with diameter of ≈1.1 nm and that are separated by a molecular distance of ≈1.5 nm [37, 38]. This dense 
packing leaves little room for reducing sugar such as glucose or ribose (on the right, to scale) to penetrate within the 
fibril, suggesting that most of the glycation is likely to occur on the surface of the fibril or between different fibrils.   
 
 
In the current work we investigate the effects of physiologically relevant AGEs on collagen tissue 
mechanics, by combining multi-scale imaging and mechanical testing techniques. These experiments focus 
at the fiber and molecular scales, using advanced light microscopy and small-angle X-ray scattering (SAXS) 
techniques, respectively. In a first step, these methods were harnessed to comprehensively characterize in 
vitro tissue glycation by ribose as reducing agent, with these findings then being benchmarked against the 
more limited experiments that were possible on tissues obtained from human donors across a wide range 
of age. We report here unprecedented quantitative insight that was gained from these experiments, better 
illuminating the molecular mechanisms and mechanical effects of AGE collagen crosslinking in the dense 
collagen connective tissue of tendon.  
  
 
2. RESULTS  
 
2.1  Tissue glycation increased fluorescence associated to AGE formation in a dose dependent manner.  
Fluorometric assay was carried out after enzymatic papain digestion, in order to verify the glycation levels 
of the collagen tissues. Significant differences were detected between non-glycated and glycated rat tail 
tendon samples at all time points (3, 6 and 11 days, p < 0.05). Tendons treated with ribose showed a 
gradual increase in pentosidine-related fluorescence (328/378 nm) and exhibited over three-time higher 





Figure 2. Evidences of AGEs formation. Fluorescence was measured with wavelengths associated with pentosidine (ex 
328, em 378). Specimens were normalized by the dry weight of the samples (n = 5). 
 
 
2.2 Tissue level failure behavior and stress relaxation but not elasticity were affected by tissue glycation.  
We observed that ribose treatment heavily affected the mechanical behavior of collagen tissue during ramp 
to failure experiments (Fig. 3A). A key feature is the total loss of post yield plastic behavior, typically 
characterized by a long plateau in the stress-strain curve after inflection at the yield point. The elastic 
modulus was not significantly affected in the glycated group. Conversely, the ultimate stress was 
considerably higher (+83%, p < 0.01) and the failure strain was reduced (-22%, p < 0.01).  
Viscoelastic properties were studied by applying an incremental stretching protocol (0-6% L0 at 0.6% L0 
increments, 200s of relaxation period) to paired fascicles (n = 8) after incubating them either in ribose 
supplemented medium or in control medium for 12 days. We observed a significant decrease of stress 





Figure 3. Glycation-induced effects on tissue mechanical properties. (A1) Representative stress–strain plot from 
fascicle mechanics testing (n = 8). (A2) Changes in mechanical properties by cross-linking. (B1) Representative stress-
time relations of a control sample and a ribose-treated sample (n = 8). (B2) Averaged (± SD) stress decay at each 
applied incremental strain. * indicates statistically significant differences. 
 
 
2.3 Fiber level sliding mechanics are dramatically diminished by tissue glycation.  
Fiber mechanics was investigated using photobleached lines that were taken with a confocal microscope 
prior the relaxation experiments. Z-stacks of the collagen matrix with photobleached lines were acquired to 
study fiber kinematics between strain intervals. Analysis of fiber deformations within individual fascicles 
revealed significantly increased fiber strain in the latter half of the stretching protocol and drastically 






Figure 4. Fiber kinematics affected by ribose-induced glycation. Fiber strain (A) and interfiber sliding (B) between 
strain increments were determined from the displacements of the photobleached lines on the extracellular matrix (n = 
8). Representative strain (A2) and angle fields (B2) measured at 6% L0 applied strain. Photobleached lines of the non-
glycated fascicle display a typical waviness, in sharp contrast the photobleached lines of the ribose-treated (glycated) 
fascicle remain nearly straight throughout the entire stretching experiment. * indicates statistically significant 
differences (p < 0.05) and scale bars represent 100 µm. 
 
 
2.4 Reduced viscoelastic behavior was also confirmed at the fibril level scale.  
Collagen fibril deformation was measured as absolute and relative increase of D-periodic length. Data 
indicated that the glycation induced changes in mechanical behavior at the tissue level was reflected in a 
change in deformation mechanism at the fibril level (Fig. 5A,B). In the control samples the fibril deformed 
linearly up to D ≈70 nm, when the yield point was reached. After this point the equatorial peaks 
disappeared (i.e., the D-banding is disrupted) and the tissue entered in the plastic regime before failure. 
Conversely, glycated samples show a decreased D-period at rest (Fig. 5C) and deformed up to D ≈ 72 nm 
(Fig. 5D,E), where tissue failed with a characteristically brittle behavior. The glycated fibrils sustained a 
larger share of tissue deformation (80%), while fibrils in the control samples sustained ≈ 60% of total tissue 





Figure 5. Fibril level ramp-to-failure. Plots of the length of D-period and tissue stress as a function of time for control 
samples (A) and glycated samples (B) during ramp to failure experiments. The plots show that the changes in stress-
time curves are due to changes in deformation mechanisms at the fibril level. In particular, glycated samples show a 
decreased D-period at rest (C), a larger D-period at failure (D) and consequently a larger fibrillary deformation (E). The 
glycated fibrils sustain a larger share of tissue deformation (80%), while fibrils in the control samples sustain ≈ 60% of 
total tissue strain and the ratio is further reduced at larger strain (F).    
 
 
The reduced viscoelastic behavior observed at the tissue and fiber scale was also confirmed at the fibril 
level scale. The length of the D-period was monitored during stress-relaxation tests (180 s relaxation time, 
from 0.6%L0 to 3.0%L0) (Fig. 6A). The stress relaxation observed for control samples was strictly related to 
the high degree of fibril-fibril sliding, which leads to a partial recovery of the D-period initial length. 
Conversely, the non-enzymatic crosslinks introduced by ribose incubation lead to a total loss of fibril sliding 
and hence the lack of D-period relaxation (Fig. 6B). 
We further investigated the ability of collagen samples to recover the fibrillar organization (i.e., D-period) 
after stretching to 4% L0, 8% L0 and 12% L0. We observed that the control samples were able to recover the 
initial length of the D-period after the removal of the load, even if during the stretching to larger 
deformation the D-banding temporarily disappeared (see Fig. S1A in Supplementary Information). 
However, the intensity of the 3rd equatorial peak showed a marked decrease following the stretching to 8% 
L0 and 12% L0, suggesting damage to the tissue integrity. Conversely, glycated samples were able to recover 
the length of the D-period after load removal but also the intensity of the 3rd peak was unaffected (Fig. 





Figure 6. Fibril level stress relaxation. Plot of D-period length as a function of time during stress relaxation 
experiments (A). Glycated samples showed a greatly reduced D-period relaxation (< 5%) compared to control samples 
(B).          
 
 
2.5 Completely different loading mechanisms at the sub-fibrillar level after glycation.  
The ratio of intensities of the 2nd and 3rd order reflections was analyzed to assess changes in length of the 
overlap region and gap region during the ramp-to-failure experiments [36, 39]. The control fibrils showed 
three distinct loading mechanism at the sub-fibrillar scale (Fig. 7A,B). In the first phase the fibril 
deformation took place only in the gap region, while the overlap region was unaffected. Onset of the 
second phase was observed when the D-period reached a value of 68.5 nm (which occured halfway in the 
linear region of the stress-time curve). In this phase the gap was observed to increase while the overlap 
decreased. Finally, when the D-period reached a mean value of 70.2 nm the D-banding was apparently lost 
and the tissue entered into a plastic regime before failure.  
Throughout the whole ramp-to-failure experiment, glycated samples exhibited a single deformation 
mechanism by which the D-period increased, likely due to a concurrent increase of the gap region and to a 
smaller extent a decrease of the overlap region (Fig. 7C,D). When the D-period reached a mean value of 
72.2 nm, the equatorial reflections disappeared, indicating a loss of D-banding that was rapidly followed by 









 order equatorial 
collagen reflections were used to determine the relative contribution of gap and overlap regions to the D-period 
deformation for control samples (A, B) and glycated samples (C,D). During the ramp to failure experiment, the control 
fibrils showed a first phase in which only the gap region (red) carried the deformation, while the overlap region (blue) 
was largely unchanged. This phase ended (1) when the D-period reached a value of 68.5 nm, which corresponded to 
the first half of the linear region in the stress-time curve (B). In a second phase the gap increased while the overlap 
decreased. This phase ended when the D-period reached 70.2 nm (2), which corresponded to the yield point. After this 
point the equatorial SAXS diffractions disappeared with the stress-strain curves entered into a plastic regime before 
failure. In contrast, the overlap region glycated fibrils (panel C in blue) decreased from the start of the loading test, and 
the tissue showed a single subfibrillar loading mechanism before the D-period was lost (point (1), at 72.2 nm), which 
corresponds to the failure of the tissue (D).                 
 
 
2.6 Human tissue display characteristic D-banding and molecular spacing observed in vitro. 
In order to further investigate the effect of glycation and AGE crosslinks on collagen mechanics we 
performed SAXS-coupled mechanical tests on human tendon tissues (n=25), with donor ages ranging from 
16 to 89 year and thus with different degrees of AGEs accumulation. The level of glycation was semi-
quantitatively tested through fluorescence analysis. The results showed a strong correlation between donor 
age and pentosidine-related fluorescence (R2 = 0.642, p < 0.01) (Fig. 8A). The tissue-level mechanical data 
(i.e., elastic modulus, yield stress, yield strain, failure stress, failure strain) were highly scattered, with no 
direct correlation to donor age (Fig. S2). Concerning the fibril-level characterization from SAXS data, the 
older human tissues showed a clear decrease in length of the D-period at rest (Fig. 8B), from ≈67.5 nm at 
younger ages to ≈67.0 nm at the oldest aged specimens (R2 = 0.477, p < 0.01). This is in line with observed 
behavior in glycated RTTFs versus controls. The molecular distance at rest showed a clearly increasing trend 
(R2 = 0.784, p < 0.01) with donor age, ranging from ≈1.45 nm at younger age to ≈1.5 nm at older age (Fig. 
8C). A similar increase in molecular distance is observed for the in vitro glycated RTTFs. However, the high 
variability in the human data and low number of specimens precluded confirmation of the mechanical 
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effects at the fibril level observed using the highly controlled RTTF in vitro glycation model (e.g., larger fibril 
deformation at failure or lack of fibril relaxation) (Fig. S3).   
 
 
Figure 8. Glycation effects in vivo. Fluorescence levels (arbitrary units normalized by the dry weight of the samples) as 
a function of donor age, assessed with the set of wavelength associated to pentosidine (A). Age and glycation led to a 
clear decrease of fibrillar D-period (B) and to an increase of molecular spacing (C), consistent with observations from in 







Advanced glycation end-products can dramatically affect collagen tissue viscoelasticity and molecular 
deformation [36]. On the basis of our early findings, the present study sought to clarify mechanisms behind 
these behaviors and verify that they occur in naturally aged, native tissue. We comprehensively 
investigated AGE mechanical effects at different hierarchical levels of tendon, from the tissue to fiber, to 
fiber-fiber interactions, to fibril-fibril interactions, and ultimately at the sub-fibril scale. In these 
experiments we used ribose as in vitro glycation agent to induce AGEs formation. Ribose has a substantially 
higher reactivity compared to glucose that facilitates its value as an experimental model  and further has 
the ability to prevalently form pentosidine, a physiologically relevant fluorescent lysine-arginine crosslink 
[13]. We then compared the results obtained with in vitro glycation against those obtained using human 
tendon specimens from donors spanning a wide range of age. Aged human tissues are known to 
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progressively accumulate AGEs over time, due to the irreversible nature of non-enzymatic crosslinking and 
low turnover of collagen.    
 
At the tissue level, ribose cross-linked specimens showed a clear loss of stress relaxation behavior, which is 
consistent with our previous studies [36, 40] where AGEs were induced by methylglyoxal treatment, a 
substantially more reactive compound. This reduction in viscoelasticity can be attributed to changes at 
lower hierarchical levels, i.e. the fiber and the fibril levels. 
 
At the fiber level, we used confocal microscopy techniques to quantify fiber kinematics from the 
displacements of photobleached lines [41-43] in response to tissue-level mechanical stretch. This scale level 
is particularly of interest, as cell-matrix interaction and the associated mechanotransduction are likely to be 
affected by matrix glycation. A key quantitative finding of the present work is the markedly reduced fiber-
fiber sliding after ribose glycation, as detected by analyzing the fiber kinematics between strain intervals. 
Photobleached fiducial markation lines on non-glycated fascicles exhibited a pronounced undulation (a 
proxy for interfiber sliding), in sharp contrast the photobleached lines on the glycated fascicles displayed a 
nearly complete lack of sliding as indicated by their remaining practically straight throughout the entire 
experiment (Fig. 4). In addition, analysis at higher applied strains of the matrix revealed a considerable 
increase in fiber strain in cross-linked fascicles compared to the control fascicles, consistent with the 
physical compensation for any loss of fiber-fiber sliding [40]. 
 
Small-angle X-ray scattering was used to determine the effect of glycation at the fibril level. The key, and 
previously unknown, finding of the present work was the observation of significant loss of fibril-fibril sliding 
that lead to a substantially altered tissue deformation mechanism that is largely based on the elastic 
deformation of the fibrils until brittle failure of the tissue (Fig. 5F). Indeed, in control samples the fibrillar 
deformation represented 40-60% of the total deformation of the tissue, whereas in glycated samples the 
fibril deformation reached levels beyond 80% of the tissue deformation. Similarly, glycated samples did not 
show D-period recovery during stress relaxation experiments (Fig. 6) suggesting the suppression of viscous 
sliding between fibrils. The fibril deformation mechanism was also drastically affected (Fig. 7). The control 
samples showed three distinct deformation mechanisms, characterized by (1) increase of gap region, (2) 
increase of gap region concurrent to a decrease of overlap region and (3) loss of D-banding (corresponding 
to the post-yield plastic regime). Conversely, glycated samples showed a unique (and previously 
unknown/unreported) deformation mechanism with the concurrent increase of gap region and decrease of 
overlap region until the loss of D-banding, which corresponds to the sample brittle failure. 
      
Beyond the identification of previously unknown glycation driven changes in collagen deformation 
mechanisms, we ran what is to our knowledge the first series of SAXS-coupled mechanical tests on human 
tendon samples aiming to characterize effects that in vivo collagen glycation during the aging process may 
have on collagen function. The aim was to compare these results to those of the in vitro glycation model. 
Interestingly, the human tissue SAXS data confirmed the decrease of D-period length and the increase of 
molecular spacing observed using the in vitro glycation models (Fig. 8), providing a valuable confirmation of 
their physiological relevance. These effects were highly consistent across samples, a striking fact 
considering the extremely large macroscopic and microscopic variability between donor tissue that 
precluded meaningful statistical comparison to other effects induced by in vitro glycation.  
 
Inability to draw clear conclusions from the presented data on human tissues under mechanical load is not 
only attributed to biological variability, but particularly to difficulty in specimen dissection and handling. 
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Indeed, while intact functional tendon units are easily extracted from a rat tail with a geometry that can be 
straightforwardly characterized, the isolation of fascicles from human samples is nearly impossible without 
damaging them. We thus resorted to cutting small strips of tendon tissue, which although geometrically 
reproducible also leads to partial and unavoidable tissue damage that adds substantial noise to SAXS based 
measurements. These factors are expected to play at least a minor role in the high experimental variability 
in the mechanical loading tests, compared to the clear cSAXS findings obtained for the unloaded samples.    
 
Although a few preferential sites for AGE formation have been discovered at the molecular level [17], the 
location of AGEs within the tissue itself until now remained unclear. Our work strongly supports that 
glycation primarily affects fibril-fibril and fiber-fiber sliding and thus the surface of the fibrils (although the 
increase in molecular distance implies diffusion of glucose within the fibril). The alteration of fibril surface 
properties and behavior could potentially affect the cell-collagen binding and the associated focal adhesion 
mediated signaling, the behavior of the stretch activated ion channels (SACs) and sliding activation of the 
primary cilium, as well as the manner in which the nucleus deforms under mechanical stress [44]. Those 
mechanisms and pathways may play a crucial role in the mechanotransduction of tendon cells, therefore it 
is feasible that changes in the extracellular matrix can have adverse effects on the cell-mediated tissue 
homeostasis and repair. The fact that glycation occurs primarily on the fibril surface and thus at an 
accessible location could have also important implication for therapeutic strategies based on enzymatic 
deglycation [45, 46].  
 
The present study has some limitations that must be considered. First, the formation of AGEs and cross-
links induced by ribose treatment was not directly quantified, however previous investigations have 
provided direct molecular evidence for pentosidine formation in tissue incubated with ribose [47, 48]. 
Additionally, in this work the indirect measurements of AGE formation by fluorescence showed clear 
changes after ribose treatment, comparable to the previous reports [47-49]. A further potential weakness 
concerns the physiological importance of the in vitro established aging-model. The high ribose 
concentrations used to acutely induce AGE cross-links are non-physiological and the incubation period does 
not directly represent the in vivo glycation process. Therefore, cell-based matrix adaptations that would 
take place in vivo as a reaction to the AGE accumulation were not considered in this study. However, the 
employed aging-model prevents critically confounding factors, e.g. due to loss of collagen, diseases and 
lifestyle. Hence, future study should be directed to further investigate the in vivo effects of glycation to 
confirm the mechanisms observed with in vitro glycation.  
 
 
4. MATERIALS AND METHODS 
 
4.1 Rat tail sample preparation. 
Skeletally mature Brown Norway rats (20 weeks old, male) were euthanized by isoflurane inhalation for an 
unrelated study, according to state and federal regulations. Rat tails  were removed and stored at -20°C 
until the day of the experiment, which has been shown not to affect tendon mechanics [50]. Individual rat 
tail tendon fascicles (RTTFs) were gently extracted from the middle region of the tail, subsequently cut into 
two equal parts and assigned either to the glycated group or to the non-glycated control for paired analysis. 
In specimens of the glycated group, AGEs were induced by incubation with 1 M D-ribose (Sigma-Aldrich, 
R7500) in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich, D6429) supplemented with 10% 
Fetal Bovine Serum (FBS, Gibco, 10270), 1% Penicillin Streptomycin (Sigma-Aldrich, P4333), 1% non-
essential amino acids (Sigma-Aldrich, M7145) and 0.1% β-Mercaptoethanol (Sigma-Aldrich, M6250). RTTFs 
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of the non-glycated group were incubated in DMEM containing the same components as for the glycated 
group but without D-ribose. All samples were incubated under sterile conditions at 29°C for 12 days in a 
temperature-controlled incubator (5% CO2, 70% humidity). 
 
4.2 Human tendon sample preparation. 
All human tissue collection and experiments performed for this study were approved by the Ethical Review 
Board of the Canton of Zurich, and informed consent was given by all donors.  Tendon tissue samples were 
obtained either from excess tendon graft material used in the reconstruction of the knee ligaments 
(semitendinosus, gracilis tendons) or from full tendons dissected from amputated extremities of diabetic 
patients. Tendons were stored at -20°C in PBS soaked gauze and used solely for the SAXS experiments. 
Samples were prepared immediately before the experiment by cutting a small piece of tissue (3 mm x  1 
mm x 30 mm) using published methods [51, 52]. A few layers of paper were glued at the terminal ends (5 
mm on both sides) to protect the tendon during clamping. 
 
4.3 AGEs quantification by collagen associated fluorescence. 
A fluorometric assay was carried out to assess the effects of the ribose treatment on the formation of AGEs 
in RTTFs and the different level of AGEs in tissues from human donors [36, 53]. Ribose treated, ribose  
control fascicles and samples from human donors were vacuum dried (RTTF: 16 h, human: 30h) to 
determine the dry weight and then digested (RTTF: 16 h, human: 72h) at 65°C with 0.2 mg/ml papain 
(Sigma-Aldrich, P4762) in PBE buffer (100 mM phosphate, 10 mM EDTA, pH 6.5) [53]. After centrifuging the 
samples at 8000 g for 1 h, triplicate aliquots of all supernatants were assayed for fluorescence using a 
microplate spectrofluorometer (SPECTRAmax GEMINI XS, Molecular Device, USA). Sample fluorescence was 
measured using 328 nm excitation (ex) and 378 nm emission (em), corresponding to the wavelengths used 
to detect and quantify pentosidine, the major crosslinking AGE resulting from ribose glycation [49]. The 
fluorescence readings were normalized to the dry weight of the samples. 
 
4.4 Photobleaching-coupled mechanical testing. 
We used photobleached lines made on the surface of collagen fascicles with confocal microscope in order 
to investigate single fiber stretching and sliding in stress relaxation tests, and in particular to assess the 
effect of AGEs on tissue micromechanics.  
Following AGE induction, the extracellular matrix (ECM) of RTTFs (n = 8) was stained. Each fascicle was 
incubated for 20 min at room temperature in a 5-(4, 6-Dichlorotriazinyl) Aminofluorescein (5-DTAF, Life 
Technologies, D16) solution (100 μg/ml 5-DTAF and 0.1 M sodium bicarbonate buffer at pH 9.0). This ECM 
fluorescent dye binds to free amine groups of collagen and it has been used in previous publications to 
visualize collagen tissues [41, 42, 54]. 
The sample was then mounted on a custom-designed tensile stretching device consisting of two motorized 
linear stages (Zaber Technologies Inc., A-LSQ075A-E01) and a 20 N load cell (Transmetra GmbH, KD24S), 
placed on the stage of an iMic spinning disc confocal microscope (FEI/Till Photonics) equipped with a 
Hamamatsu Flash 4.0 sCMOS camera and a SOLE-6 Quad laser (Omicron) (Fig. 9A1). The RTTF was 
immersed in a PBS bath to maintain tissue hydration throughout the experiment. The cross-sectional area 
and the initial length L0 (from clamp-to-clamp) of the sample were measured at collagen fiber crimp 
(macroscopic fascicle waviness) disappearance. The tissue strain was defined as strain εT = (L - L0)/L0 in 
percentage, with L being the sample length. Before all mechanical tests, the RTTF was preconditioned ten 
times up to 1.0% L0. Subsequently, at L0 two sets of five lines separated by 100 μm were photobleached 
onto the fascicle’s surface in the central region of the sample with a 488 nm diode laser (Fig. 9A2). Such an 
approach has been used in previous studies to investigate local mechanics in collagen tissues [41-43]. At 
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this point, relaxation experiment was conducted, applying strains from 0 to 6% L0 to each sample at 0.6% L0 
increments with a constant strain-rate of 0.5% L0/s and a relaxation period of 200 s. The force readings 
were normalized to tissue stress by the cross-sectional area. At every strain increment image stacks (200 
planes, 1 μm distance between planes, 1024 x 2660 px) of the collagen matrix with photobleached lines 
(488 nm excitation, 516 nm emission) were taken after a relaxation period of 60s (majority of relaxation) 
using a 10X objective (Olympus, UPLSAPO, N.A. 0.4). Due to the curved surface of the fascicle, image stacks 
were necessary. 
 
4.5 Image Analysis. 
After the image acquisition, Z-stacks were converted to single composite images using the standard 
deviation projection method in ImageJ (v1.49p). ECM deformation was assessed by image post-processing 
of the photobleached lines, based on Szczesny and Elliott [42]. Briefly, pixel intensities of the composite 
image were acquired with a custom Matlab algorithm (Fig. S4A). The location of the five photobleached 
lines (lowest intensity) was used to determine fiber strain and interfiber sliding (Fig. S4B).  Fiber strain was 
calculated as the change in distance between two neighboring lines. Interfiber sliding was determined as 
the angle (α) between each photobleached line and the direction perpendicular to the fascicle axis (y-
direction). The overall amount of interfiber sliding was calculated from the spread of the computed angle, 
i.e. the standard deviation was determined of the angle averaged across the five photobleached lines (Fig. 
S4C). The fiber strain and interfiber sliding averaged across the two sets of photobleached lines were used 
for statistical analysis. 
 
4.6 Mechanical testing coupled with small-angle X-ray scattering.  
SAXS coupled with mechanical testing was used to investigate the effects of glycation at the fibril and 
molecular level during ramp-to-failure and relaxation experiments. Collagen fibril deformation during 
tendon tensile loading was measured at the coherent small-angle X-ray scattering beamline at the Swiss 
Light Source, Paul Scherrer Institute, Switzerland. Paired RTTFs (n=8) were tested after incubation in control 
solution or in the presence of 1 M ribose for 12 days.   
Following sample preparation, as described before, fascicle-clamp assemblies were mounted on a custom-
built tensile testing apparatus (linear stepper motor: NA23C60, accuracy 40 µm, Zaber Technologies Inc., 
Vancouver, Canada; load cell: KD24S, 20 N, accuracy: 0.1 %, Transmetra, Switzerland) with a custom-
designed control software (LabVIEW, National Instruments). A precision X-Y table was used to adjust the 
axial sample alignment. The tensile tester was a modification of an available micro-compression device 
[55], which was designed to fit on the stage of the coherent small-angle X-ray scattering (cSAXS) beamline 
at Swiss Light Source (Paul Scherrer Institute, Switzerland). During all experiments two 4 μm Ultralene films 
(X-ray semitransparent material) were placed on two sides of each tendon held together by a drop of PBS 
to maintain tissue hydration [56].  
 
To measure collagen fibril deformation during tendon loading we used SAXS with a X-ray wavelength of 0.1 
nm obtained from a double-crystal Si (111) monochromator and a beam cross-section at the sample 340 
μm width and 300 μm height obtained by slight focusing using bendable monochromator crystal and high-
order rejection mirror. The specimens were placed ~12 mm upstream the entrance window of an 
evacuated 2.1 m flight tube. 2D diffraction patterns were recorded with an in-house developed PILATUS 2M 
detector (array size: 1475 × 1679 pixels; pixel size: 172 × 172 μm2; active area: 254×289 mm2) [57]. The 
total sample to detector distance (2.178 m) and the center of the direct beam on the detector were 
calibrated using silver behenate. During ramp-to-failure tests, the SAXS frames were collected with an 
acquisition time of 200 ms concurrently during mechanical testing with the Pilatus detector being triggered 
16 
 
by the testing apparatus software via TTL pulses. Conversely, during stress relaxation experiments the 
frames were acquired at exponentially increasing time intervals subsequent tissue strain increments of DeT 
= 0.6 % L0 (up to 3% L0) This exponential curve matched previous published collagen fibril relaxation by 
Gupta [56] and allowed a most optimal acquisition of data where collagen deformation occurred. A shutter 
closing between frames reduced the X-ray dose at the sample. 
 
The collected 2D SAXS patterns showed the 2nd to 36th order equatorial collagen reflections due to the D-
banding and the meridional reflection due to molecular spacing (Fig. 9B1). Azimuthal integration was 
carried out over angular sectors of 22.5° width centered at the calibrated location of the direct beam on 
the detector. From the resulting 1D intensity profiles [averaged photons per pixel] versus q [nm-1] a two 
term exponential background was subtracted (empirically determined best fit). The equatorial peak 
position, height and width (FWHM) were estimated by fitting a series of Gaussian curves to the first 8 order 
collagen reflections using non-linear least squares (OriginPro 8.6; Matlab R2013a) (Fig. 9B2,4). The collagen 
fibril D-spacing was calculated as D = 2 π/Δq, where Δq is the average spacing between the peak positions. 
Either absolute or normalized change of D-spacing served as averaged measures of collagen fibril 
elongation: collagen fibril deformation (ΔD = D - D0) and collagen fibril strain (eF = D / D0 - 1 [%]) with D0 as 
D-period length at pre-stress/start of experiment. For each relaxation step, collagen fibril relaxation was 
measured as the relative shortening of the D-period length normalized to the D-period length (D0,s) at start 
of the relaxation step: DeF = D / D0,s - 1 [%]. The meridional peak position, height and width (FWHM) was 
estimated by fitting a single Gaussian curve and the molecular distance calculated as d = 2π/q (Fig. 9B3). 
 
 
Figure 9. Advanced multiscale imaging techniques. (A) Experimental setup for matrix level mechanical tests: RTTFs 
were clamped in a custom stretching device mounted on the stage of a confocal microscope (A1). Representative 
monochrome image showing the two sets of five photobleached lines to track collagen fiber sliding and stretch (A2). 
Scale bar represents 100 µm. (B) SAXS experiments: the 2D SAXS diffraction pattern (B1) recorded from tendons are 
dominated by the strong meridional reflection of a spacing about ≈ 1.4 nm and by the equatorial meridional Bragg 
reflections corresponding to ≈ 67.5 nm and harmonic frequencies of this spacing (B2). The meridional reflections 
(yellow square) are used to determine the molecular spacing (B3), while the equatorial intensities (red square) are 
integrated azimuthally, which resulted in 1-D intensity profiles (q [nm
-1
] vs. I [average photons per pixel]). The 
equatorial peak positions (red square) are used to calculate the length of the D-period (B4). Changes of the peak 






4.7 Statistical Analysis. 
Parameters derived from the experiments on RTT fascicles were analyzed using two tailed unpaired student 
T-tests, one-way ANOVAs and two-way ANOVAs. Correlation between age and human tissue parameters 
were assessed through Pearson’s coefficient. Statistically significant differences were defined as p < 0.05 
(indicated with an asterisk in the figures). Results were reported as means ± standard deviations. All 
statistical analyses were performed with GraphPad Prism 6. 
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